Champions Oncology: Q3 Earnings Insights
Champions Oncology: Q3 Earnings Insights
Champions Oncology (NASDAQ:CSBR) reported its Q3 earnings results on Tuesday, March 12, 2024 at 04:00 PM.
Champions Oncology（纳斯达克股票代码：CSBR）于2024年3月12日星期二下午4点公布了其第三季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Champions Oncology missed estimated earnings by -7.000000000000001%, reporting an EPS of $-0.16 versus an estimate of $-0.15.
Champions Oncology报告每股收益为-0.16美元，低于预期收益-7.00000000001％，而估计为-0.15美元。
Revenue was down $754 thousand from the same period last year.
收入比去年同期下降了75.4万美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.02 which was followed by a 5.0% increase in the share price the next day.
上个季度，该公司的每股收益高出0.02美元，随后第二天股价上涨了5.0％。
Here's a look at Champions Oncology's past performance:
以下是 Champions Oncology 过去的表现：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.10 | -0.12 | -0.03 |
| EPS Actual | -0.15 | -0.16 | -0.17 | -0.16 |
| Revenue Estimate | 12.84M | 13.06M | 12.86M | 13.13M |
| Revenue Actual | 11.57M | 12.56M | 13.07M | 12.77M |
| 季度 | 2024 年第二季度 | 2024 年第一季度 | 2023 年第四季度 | 2023 年第三季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.17 | -0.10 | -0.12 | -0.03 |
| 实际每股收益 | -0.15 | -0.16 | -0.17 | -0.16 |
| 收入估算 | 12.84 亿 | 13.06M | 12.86 米 | 13.13 米 |
| 实际收入 | 11.57 亿 | 12.56 米 | 13.07 米 | 12.77M |
To track all earnings releases for Champions Oncology visit their earnings calendar here.
要追踪Champions Oncology的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。
译文内容由第三方软件翻译。